Epigenetic Drug Targets Fat, Improving Blood Vessel Health

Scientists have targeted the thin fat layer around blood vessels with a transcription inhibitor, reducing symptoms of cardiometabolic disease [1]. When vessels can’t “just relax” Cardiometabolic disease (CMD) – characterized, among other things, by obesity combined with high […]

This story was reported by Lifespan Research Institute. EUROPES curates Europe's most relevant coverage — read the full report at the original source.